Real‐Time Auto Controlling of Viable Cell Density in Perfusion Cultivation Aided by In‐Line Dielectric Spectroscopy With Segmented Adaptive PLS Model
Biotechnology and Bioengineering · 2025-04 · 122 (4) · 858-869
DOI: 10.1002/bit.28930 ↗At a glance
Journal article in Biotechnology and Bioengineering, published online on 2025-01-17. Written by Yunpeng Sun and 7 co-authors. Institution: Cell Culture Process Development (CCPD), WuXi Biologics, Shanghai, China. Major MEDLINE topics: Dielectric Spectroscopy, Cell Culture Techniques. Cited 9 times so far (Crossref); 30 references.
Abstract (original language)
Serving as a dedicated process analytical technology (PAT) tool for biomass monitoring and control, the capacitance probe, or dielectric spectroscopy, is showing great potential in robust pharmaceutical manufacturing, especially with the growing interest in integrated continuous bioprocessing. Despite its potential, challenges still exist in terms of its accuracy and applicability, particularly when it is used to monitor cells during stationary and decline phases. In this study, data pre‐processing methods were first evaluated through cross‐validation, where the first‐order derivative emerged as the most effective method to diminish variability in prediction accuracy across different training datasets. Subsequently, a segmented adaptive partial least squares (SA‐PLS) model was developed, and its accuracy and universality were demonstrated through several validation studies using different clones and culture processes. Furthermore, a real‐time viable cell density (VCD) auto‐control system in perfusion culture was established, where the VCD was maintained around the target with notable precision and robustness. This model enhanced the monitoring capabilities of capacitance‐based PAT tools throughout the cultivation, expanded their application in cell‐specific automatic control strategies, and contributed vitally to the advancement of continuous manufacturing paradigms.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Cell Culture Process Development (CCPD), WuXi Biologics, Shanghai, China.
- Non-GMP Pilot Plant (NPP), WuXi Biologics, Shanghai, China.
- Bioprocess Research and Development (BRD), WuXi Biologics, Shanghai, China.
ORCID profiles: Zheyu Wang, Xiang Zheng, Hang Zhou
Cite
APA
Sun, Y., Zhang, Q., He, Y., Chen, D., Wang, Z., Zheng, X., Fang, M., & Zhou, H. (2025). Real‐Time Auto Controlling of Viable Cell Density in Perfusion Cultivation Aided by In‐Line Dielectric Spectroscopy With Segmented Adaptive PLS Model. Biotechnology and Bioengineering, 122(4), 858-869. https://doi.org/10.1002/bit.28930
Vancouver
Sun Y, Zhang Q, He Y, Chen D, Wang Z, Zheng X, et al. Real‐Time Auto Controlling of Viable Cell Density in Perfusion Cultivation Aided by In‐Line Dielectric Spectroscopy With Segmented Adaptive PLS Model. Biotechnology and Bioengineering. 2025;122(4):858-869. doi:10.1002/bit.28930
BibTeX
@article{Sun2025,
author = {Sun, Yunpeng and Zhang, Qiongqiong and He, Yunfei and Chen, Dongliang and Wang, Zheyu and Zheng, Xiang and Fang, Mingyue and Zhou, Hang},
title = {Real‐Time Auto Controlling of Viable Cell Density in Perfusion Cultivation Aided by In‐Line Dielectric Spectroscopy With Segmented Adaptive PLS Model},
journal = {Biotechnology and Bioengineering},
year = {2025},
volume = {122},
number = {4},
pages = {858--869},
doi = {10.1002/bit.28930}
}
EUVIMED